華禧聯(lián)合科技，歷時(shí)10年打造的新藥技術(shù)開(kāi)發(fā)與管理團(tuán)隊(duì)，持續(xù)提高企業(yè)創(chuàng)新能力與國(guó)際化程度，已從研發(fā)環(huán)境、儀器設(shè)備、人員配置、質(zhì)量體系以及管理系統(tǒng)各層面對(duì)接國(guó)際標(biāo)準(zhǔn)。
華禧聯(lián)合科技，基于10年的新藥開(kāi)發(fā)積累，與專(zhuān)業(yè)投資機(jī)構(gòu)一起，通過(guò)并購(gòu)重組，成功實(shí)現(xiàn)企業(yè)向產(chǎn)業(yè)化轉(zhuǎn)型。原料藥、口服固體制劑自主開(kāi)發(fā)，生產(chǎn)線(xiàn)對(duì)接國(guó)際GMP認(rèn)證，產(chǎn)品主要對(duì)接國(guó)外市場(chǎng)；鼻噴劑、滴眼劑等液體制劑主要承接國(guó)際技術(shù)轉(zhuǎn)移及加工合作，生產(chǎn)線(xiàn)對(duì)接國(guó)際GMP認(rèn)證。
華禧聯(lián)合科技，期待通過(guò)與**企業(yè)的合作，向國(guó)際市場(chǎng)提供更具社會(huì)效益的高質(zhì)量藥品，使華禧聯(lián)合科技成為一家倍受尊敬的國(guó)際制藥企業(yè)。
Huaxipharm has new drug technology and management teams with 10 years’ experience. Huaxipharm keep improving creating ability and degree of internationalization, and has complied with international standard on multiple levels, such as R&D environment, lab equipment, human resource allocation, file system and management system.
Huaxipharm, based on 10 years experience of new drug R&D, achieve the industrialization of the enterprise transformation successfully by a new round of acquisition and reorganization. Huaxipharm’s API and Oral solid preparation are developed independently. Production line of API and Oral solid preparation is facing international GMP certification and products are designed for foreign markets. For liquid preparation, such as nasal spray and eye drop, Huaxipharm is look for cooperation as technology transfer and OME. Production line of liquid preparation is facing international GMP certification.
Huaxipharm is looking forward to cooperate with outstanding enterprises, and provide high quality medicines of social benefits for international market, thus making Huaxipharm a respected international pharmaceutical company. |
您當(dāng)前的位置: 首頁(yè) > 企業(yè)名錄 > 公司介紹 
